GENOME RESEARCH LIMITED

Registered charity 1021457 · accounts filings on the Charity Commission register · also known as WELLCOME TRUST SANGER INSTITUTE

A) TO ADVANCE RESEARCH INTO AND INVESTIGATION OF THE HUMAN GENOME AND TO PUBLISH THE USEFUL RESULTS OF SUCH RESEARCH B) TO ADVANCE SCIENTIFIC AND MEDICAL RESEARCH

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Financial health, per its FY2025 accounts

The accounts state that total net assets increased to £273.7 million, supported by a pension surplus of £108.2 million and unrestricted income funds of £24.4 million. The charity reports net current assets of £36.2 million and confirms that core funding from Wellcome is sufficient to meet obligations for the foreseeable future. The trustees are satisfied that the going concern basis is appropriate, with no material uncertainties identified.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Accounts audited by Deloitte LLP. Discloses 3 of 6 completeness components.

In the news

Recent coverage mentioning this charity by name (automated match; headlines belong to their publishers).

• The Wellcome Trust Sanger Institute - premierconstructionnews.com · 02/06/2015

Funders the charity credits

Named as funders/supporters on the charity’s own website (the charity’s claim, distinct from accounts-verified grants).

• Wellcome — “Since 1992, Wellcome has invested in the Sanger Institute to deliver bold, long-term discovery science at scale, by developing and deploying…” (source page)

UK research funding (UKRI Gateway to Research)

• Cambridge Autonomous Bus System Feasibility Study —
• High-speed single molecule detection combining short DNA probes and barcoding bioinformatics for use as a new broad spectrum point-of-care diagnostic —
• Personalised iPS Cell Culture System —

Property (HM Land Registry)

1 registered title in England and Wales held by the charity’s company or corporate body (0 freehold). All charity-held property. Contains HM Land Registry data © Crown copyright, OGL v3.0.

Public profiles (found on the charity’s own website): facebook (10,375 likes)

Structured financials (annual return, FY ending 30/09/2025)

Reported reserves equal ~2.1 months of spending — below the median for charities its size (median 2.7 months; benchmarks).

Per its annual return, largest income source: Charitable activities (91% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 0.0% of total income — below the median for charities its size (2.9%) (benchmarks).

Trustees · trustee networks

• Dr John-Arne Rottingenchair · trustee of 1 other charity
• Caroline Relton
• Daniel Abrams
• Dr Nicole Mather
• Karen Chadwick
• Mark McCarthy
• Matthew Newcombe-Ellis · trustee of 1 other charity
• Michael Dunn

Trustee list from the Charity Commission register (current, not historical).

Operates in: Cambridgeshire

Income and spending

Common questions

Known funders

Grants to this charity found in funders’ own accounts filings.

Government & lottery funding

Grants to this charity published as open data by government and lottery funders (360Giving).

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with GENESIS AMERICA (UK) LIMITED.

• GENESIS AMERICA (UK) LIMITED income £1.1m
• UK BIOBANK LIMITED income £68.9m
• STRUCTURAL GENOMICS CONSORTIUM income £4.7m
• GENESIS RESEARCH TRUST income £524k
• THE LORNA AND YUTI CHERNAJOVSKY BIOMEDICAL RESEARCH FOUNDATION income £508k
• LEUKAEMIA & MYELOMA RESEARCH UK LTD income £554k

Side by side with its peers

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.